Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience

Table 1 Patient demographics

Male:female	44:13
Age, median (IQR)	59.1 (53.5-63.6)
Aetiology of HCC
Alcoholic liver disease	17 (29.8%)
Hepatitis C	17 (29.8%)
Haemochromatosis	13 (22.8%)
α-1-antitrypsin deficiency	3 (5.3%)
Primary sclerosing cholangitis	2 (3.5%)
Primary biliary cirrhosis	2 (3.5%)
Autoimmune hepatitis	2 (3.5%)
Hepatitis B	2 (3.5%)
Cryptogenic	2 (3.5%)
Cystic fibrosis	1 (1.8%)
Sarcoidosis	1 (1.8%)
Nash	1 (1.8%)
Pre-operative α-fetoprotein, median (IQR)	8.8 (3.3-29.2)
Compliant with Milan criteria	41 (71.9%)
Compliant with UCSF criteria	49 (86.0%)
Largest lesion, median (IQR)	3 (2.5-4.5)
Cirrhosis	53 (93.0%)
Steatosis	2 (3.5%)
Multifocal lesions	24 (42.1%)
Micro-vascular invasion	24 (42.1%)
Tumour differentiation
Well	24 (42.1%)
Moderate	28 (49.1%)
Poor	5 (8.8%)
Incidental lesions	5 (8.8%)

HCC: Hepatocellular carcinoma; UCSF: University of California San Francisco; IQR: Interquartile range.